News Search Results

Displaying Results 801-802 of 802 "cns"
Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.
NLS Pharmaceutics CEO Issues Letter to Shareholders

Mar 10, 2025, 07:00 ET NLS Pharmaceutics CEO Issues Letter to Shareholders

Pharmaceutics Ltd. (NASDAQ: NLSP), a Swiss clinical-stage biopharmaceutical company focused on developing innovative therapies for central nervous system (CNS) disorders, today issued a letter to its shareholders.

More news about: NLS Pharmaceutics Ltd.

Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.